{"gene":"NDUFV2","run_date":"2026-04-29T11:37:56","timeline":{"discoveries":[{"year":1995,"finding":"NDUFV2 encodes the 24-kDa iron-sulfur subunit of mitochondrial complex I (NADH:ubiquinone oxidoreductase), containing a [2Fe-2S] binuclear cluster (N1a), and is located on chromosome 18p11.2-p11.31; the gene spans ~20-31.5 kb with 8 exons and has a promoter with three putative GC boxes but no CAAT or TATA boxes.","method":"Molecular cloning, FISH chromosomal mapping, genomic sequencing","journal":"Genomics / Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 — independent structural and genomic characterization by two labs","pmids":["7607668","7488192"],"is_preprint":false},{"year":2003,"finding":"A homozygous 4-bp deletion in intron 2 (IVS2+5_+8delGTAA) of NDUFV2 disrupts the consensus splice-donor site of exon 2, resulting in 70% decreased NDUFV2 protein and complex I deficiency, causing early-onset hypertrophic cardiomyopathy and encephalopathy.","method":"DHPLC and sequencing of patient DNA; protein quantification in patient tissue","journal":"Human mutation","confidence":"High","confidence_rationale":"Tier 2 — direct genetic and biochemical demonstration in affected patients, replicated in subsequent studies","pmids":["12754703"],"is_preprint":false},{"year":2007,"finding":"The transcription factor Sp1 directly activates NDUFV2 transcription by binding to three GC-boxes in the NDUFV2 promoter; treatment with the Sp1/DNA binding inhibitor mithramycin inhibits both Sp1 binding to the NDUFV2 promoter and NDUFV2 transcription in neuroblastoma cells.","method":"Promoter-reporter assay, chromatin immunoprecipitation (ChIP), mithramycin inhibition in neuroblastoma cells, RT-PCR","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1–2 — direct promoter binding and functional transcription assays with multiple orthogonal methods","pmids":["17786189"],"is_preprint":false},{"year":2011,"finding":"The mitochondrial targeting sequence (MTS) of NDUFV2 resides in its N-terminal 22 residues; the cleavage site is around amino acid 32. Correct mitochondrial import requires a net positive charge and amphiphilic structure in the presequence. The disease-causing deletion mutant (mimicking IVS2+5_+8delGTAA, lacking residues 19–40) exhibits significantly impaired mitochondrial targeting, establishing impaired mitochondrial import as the pathomechanism for hypertrophic cardiomyopathy/encephalopathy.","method":"GFP fusion constructs, c-myc epitope tagging, confocal microscopy, site-directed mutagenesis of the presequence","journal":"Journal of biomedical science","confidence":"High","confidence_rationale":"Tier 1–2 — mutagenesis combined with live-cell fluorescence imaging and functional localization assay","pmids":["21548921"],"is_preprint":false},{"year":2017,"finding":"Adenosine A2 receptor activation via NECA increases mitochondrial Src tyrosine kinase activity, leading to phosphorylation of Tyr118 of NDUFV2; this phosphorylation inhibits complex I activity and reduces mitochondrial superoxide generation at reperfusion. Cells expressing the Y118F mutant of NDUFV2 show increased complex I activity and NECA fails to suppress complex I at reperfusion in these cells.","method":"LC-MS phosphoproteomics, site-directed mutagenesis (Y118F), complex I activity assay in transfected cells, isolated rat heart ischemia/reperfusion model","journal":"Free radical biology & medicine","confidence":"High","confidence_rationale":"Tier 1 — LC-MS site identification combined with mutagenesis and functional enzyme assay","pmids":["28219781"],"is_preprint":false},{"year":2018,"finding":"The NDUFV2 pseudogene NDUFV2P1 is upregulated in schizophrenia-derived cell lines and postmortem brain; NDUFV2P1 expression inversely correlates with NDUFV2 protein level (both precursor and mature forms) and with complex I-driven cellular respiration, suggesting NDUFV2P1 negatively regulates NDUFV2 protein level without affecting mRNA, contributing to complex I dysfunction.","method":"qRT-PCR for pseudogene vs. gene transcripts, Western blot for protein isoforms, Seahorse respirometry, correlation analyses in patient-derived cell lines and postmortem brain","journal":"Molecular psychiatry","confidence":"Medium","confidence_rationale":"Tier 2–3 — multiple methods in patient-derived material but mechanism of pseudogene-mediated regulation not fully reconstituted","pmids":["30531937"],"is_preprint":false},{"year":2021,"finding":"Ndufv2 overexpression in adipose tissue regulates supercomplex assembly of mitochondrial complex I and elevates mitochondrial reactive oxygen species (ROS) production, which in turn generates a retrograde signal that increases mitochondrial biogenesis; Ndufv2 controls at least 89 mitochondrial genes in a sex- and tissue-specific manner in females.","method":"In vivo overexpression in mouse adipose tissue, supercomplex assembly assay (BN-PAGE), mitochondrial ROS measurement, gene expression profiling across diverse inbred mouse strains","journal":"Nature metabolism","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic overexpression with biochemical supercomplex and ROS assays plus transcriptomic evidence","pmids":["34697471"],"is_preprint":false},{"year":2023,"finding":"PHB2 (Prohibitin 2) physically interacts with NDUFV2 and promotes its protein stabilization; PHB2 deficiency leads to downregulation of NDUFV2 protein and impairment of mitochondrial complex I activity and oxidative phosphorylation in doxorubicin-challenged hearts.","method":"Co-immunoprecipitation, pulldown assays, proteomic profiling, cardiac-specific PHB2 conditional knockout mice, in vivo and in vitro DOX cardiotoxicity models","journal":"Redox biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP and pulldown combined with genetic KO model and functional OXPHOS assays","pmids":["37451140"],"is_preprint":false},{"year":2004,"finding":"A -602G>A polymorphism in the promoter region of NDUFV2 alters promoter activity, as demonstrated by promoter assay; haplotypes containing this and a -3542G>A variant are associated with bipolar disorder in both Japanese and NIMH pedigrees.","method":"Promoter-reporter (luciferase) assay, case-control genotyping, transmission disequilibrium test","journal":"Biological psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 — functional promoter assay combined with genetic association, single lab","pmids":["15450783"],"is_preprint":false},{"year":2021,"finding":"Three novel missense mutations in NDUFV2 identified in patients with progressive cavitating leukoencephalopathy affect the structural stability and function of the NDUFV2 protein; complementation with wild-type NDUFV2 cDNA rescued complex I deficiency in patient fibroblasts.","method":"Whole-genome/exome sequencing, cDNA complementation assay in fibroblasts, complex I activity assay","journal":"Journal of medical genetics","confidence":"High","confidence_rationale":"Tier 1–2 — cDNA complementation directly links NDUFV2 loss-of-function to complex I deficiency","pmids":["33811136"],"is_preprint":false}],"current_model":"NDUFV2 encodes the 24-kDa [2Fe-2S] iron-sulfur subunit (N1a cluster) of the N-module of mitochondrial respiratory complex I; its N-terminal 22-residue amphiphilic presequence directs mitochondrial import, where it is cleaved at ~residue 32; it is transcriptionally activated by Sp1 binding to GC-boxes in its promoter; its complex I activity is negatively regulated by Src-mediated phosphorylation at Tyr118; its protein stability is maintained through interaction with PHB2; it promotes mitochondrial supercomplex assembly and ROS-driven biogenesis in a sex-specific manner; and loss-of-function mutations cause complex I deficiency manifesting as hypertrophic cardiomyopathy, Leigh syndrome, or cavitating leukoencephalopathy."},"narrative":{"teleology":[{"year":1995,"claim":"Establishing the molecular identity of NDUFV2 as the 24-kDa [2Fe-2S] complex I subunit mapped to 18p11 resolved which nuclear gene encodes this iron–sulfur center and revealed a TATA-less, GC-box-containing promoter architecture.","evidence":"Molecular cloning, FISH mapping, and genomic sequencing by two independent groups","pmids":["7607668","7488192"],"confidence":"High","gaps":["No functional demonstration that the GC-boxes drive transcription","No disease mutations yet identified","Mitochondrial import mechanism not characterized"]},{"year":2003,"claim":"Identification of the IVS2+5_+8delGTAA splice-site mutation causing 70% loss of NDUFV2 protein and complex I deficiency demonstrated that NDUFV2 loss-of-function is sufficient to cause early-onset hypertrophic cardiomyopathy and encephalopathy.","evidence":"DHPLC/sequencing of patient DNA with protein quantification in affected tissue","pmids":["12754703"],"confidence":"High","gaps":["Pathomechanism (impaired import vs. protein instability) not yet distinguished","No complementation rescue performed","Only a single family studied"]},{"year":2004,"claim":"A promoter polymorphism (−602G>A) was shown to alter NDUFV2 transcriptional activity and associate with bipolar disorder, providing the first evidence that quantitative variation in NDUFV2 expression has neuropsychiatric consequences.","evidence":"Luciferase promoter-reporter assay combined with case-control and TDT genetic association","pmids":["15450783"],"confidence":"Medium","gaps":["Association not replicated across multiple independent cohorts at the time","Downstream effect on complex I activity in brain not measured","Causal transcription-factor binding change at −602 not identified"]},{"year":2007,"claim":"Demonstrating that Sp1 directly binds the three GC-boxes and activates NDUFV2 transcription resolved the transcriptional regulation of this TATA-less gene.","evidence":"ChIP, promoter-reporter assays, and mithramycin inhibition in neuroblastoma cells","pmids":["17786189"],"confidence":"High","gaps":["Additional transcription factors or chromatin regulators not explored","Tissue-specific regulation not addressed","Link between Sp1 activity changes and disease states not tested"]},{"year":2011,"claim":"Mapping the mitochondrial targeting sequence to residues 1–22 and the cleavage site to ~residue 32 established that the IVS2-linked deletion (Δ19–40) causes disease specifically by abolishing mitochondrial import of NDUFV2.","evidence":"GFP/c-myc fusion constructs with site-directed mutagenesis and confocal microscopy","pmids":["21548921"],"confidence":"High","gaps":["Import pathway components (TIM/TOM dependence) not identified","Whether partially imported mutant protein is degraded was not shown","Complementation in patient cells not performed"]},{"year":2017,"claim":"Identification of Src-mediated Tyr118 phosphorylation as a negative regulatory switch for complex I activity revealed a rapid post-translational mechanism linking receptor signaling to mitochondrial electron transport during ischemia–reperfusion.","evidence":"LC-MS phosphoproteomics, Y118F mutagenesis, complex I activity assay, and rat heart ischemia–reperfusion model","pmids":["28219781"],"confidence":"High","gaps":["Structural basis for how pY118 inhibits electron transfer through the N1a cluster not resolved","Whether other kinases phosphorylate NDUFV2 at additional sites is unknown","In vivo significance beyond cardiac ischemia–reperfusion not tested"]},{"year":2018,"claim":"Discovery that the pseudogene NDUFV2P1 inversely regulates NDUFV2 protein level without affecting mRNA suggested a post-transcriptional layer of complex I regulation relevant to schizophrenia-associated bioenergetic deficits.","evidence":"qRT-PCR, Western blot, and Seahorse respirometry in patient-derived cell lines and postmortem brain","pmids":["30531937"],"confidence":"Medium","gaps":["Mechanism of pseudogene-mediated post-transcriptional regulation not reconstituted","Causal role of NDUFV2P1 not demonstrated by knockdown/overexpression rescue","Findings limited to correlative patient-derived material"]},{"year":2021,"claim":"In vivo overexpression of Ndufv2 in adipose tissue showed it promotes mitochondrial supercomplex assembly and ROS-driven retrograde signaling that increases mitochondrial biogenesis in a sex-specific manner, extending NDUFV2's role beyond electron transfer to organelle homeostasis.","evidence":"Mouse adipose-specific overexpression, BN-PAGE supercomplex assay, mitochondrial ROS measurement, transcriptomics across inbred strains","pmids":["34697471"],"confidence":"High","gaps":["Whether the supercomplex-assembly function is direct or secondary to increased N-module incorporation is unclear","Mechanism of sex specificity not identified","Relevance to non-adipose tissues not established"]},{"year":2021,"claim":"cDNA complementation rescue of complex I deficiency in fibroblasts from patients carrying novel NDUFV2 missense mutations confirmed causality for progressive cavitating leukoencephalopathy, broadening the phenotypic spectrum of NDUFV2-linked disease.","evidence":"Whole-exome sequencing plus cDNA complementation and complex I activity assay in patient fibroblasts","pmids":["33811136"],"confidence":"High","gaps":["Structural effects of individual missense mutations on the [2Fe-2S] cluster not resolved","Genotype–phenotype correlation across cardiomyopathy vs. leukoencephalopathy not mechanistically explained","No animal model recapitulating these specific mutations"]},{"year":2023,"claim":"Demonstrating that PHB2 physically interacts with and stabilizes NDUFV2 protein identified a chaperone-like quality-control mechanism for maintaining complex I integrity, particularly under cardiotoxic stress.","evidence":"Reciprocal Co-IP, pulldown, proteomics, cardiac-specific PHB2 knockout mice, doxorubicin cardiotoxicity model","pmids":["37451140"],"confidence":"High","gaps":["Whether PHB2 stabilizes NDUFV2 during or after mitochondrial import is unknown","Binding interface between PHB2 and NDUFV2 not mapped","Whether PHB2 similarly stabilizes other N-module subunits not tested"]},{"year":null,"claim":"A high-resolution structural understanding of how post-translational modifications (Tyr118 phosphorylation) and protein–protein interactions (PHB2 binding) regulate NDUFV2 within the assembled complex I supercomplex, and how genotype dictates tissue-specific disease manifestation, remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No atomic-resolution structure of human NDUFV2 in context of modified or PHB2-bound complex I","Mechanism underlying tissue-specific and sex-specific phenotypic outcomes not elucidated","Contribution of pseudogene NDUFV2P1 to complex I regulation awaits direct genetic perturbation"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[0,4]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,3,6,7]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,4,6,7]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[1,9]}],"complexes":["Mitochondrial complex I (NADH:ubiquinone oxidoreductase)"],"partners":["PHB2","SRC","SP1"],"other_free_text":[]},"mechanistic_narrative":"NDUFV2 encodes the 24-kDa [2Fe-2S] iron–sulfur subunit (cluster N1a) of the NADH-dehydrogenase N-module of mitochondrial respiratory complex I, serving as an essential determinant of complex I assembly, activity, and supercomplex organization. Its N-terminal amphiphilic presequence directs mitochondrial import with cleavage around residue 32, and disruption of this targeting — as occurs with the IVS2+5_+8delGTAA splice-site mutation — abolishes import and causes complex I deficiency [PMID:21548921, PMID:12754703]. Transcription is driven by Sp1 binding to GC-boxes in the TATA-less promoter [PMID:17786189]; at the post-translational level, Src-mediated phosphorylation of Tyr118 inhibits complex I activity during ischemia–reperfusion [PMID:28219781], while physical interaction with PHB2 stabilizes NDUFV2 protein and sustains oxidative phosphorylation [PMID:37451140]. Loss-of-function mutations cause complex I deficiency presenting as hypertrophic cardiomyopathy, Leigh-like encephalopathy, or progressive cavitating leukoencephalopathy [PMID:12754703, PMID:33811136]."},"prefetch_data":{"uniprot":{"accession":"P19404","full_name":"NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial","aliases":["NADH-ubiquinone oxidoreductase 24 kDa subunit"],"length_aa":249,"mass_kda":27.4,"function":"Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (Probable). Parts of the peripheral arm of the enzyme, where the electrons from NADH are accepted by flavin mononucleotide (FMN) and then passed along a chain of iron-sulfur clusters by electron tunnelling to the final acceptor ubiquinone (Probable). Contains one iron-sulfur cluster (Probable)","subcellular_location":"Mitochondrion inner membrane","url":"https://www.uniprot.org/uniprotkb/P19404/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NDUFV2","classification":"Not Classified","n_dependent_lines":325,"n_total_lines":1208,"dependency_fraction":0.26903973509933776},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CBX1","stoichiometry":0.2},{"gene":"NVL","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/NDUFV2","total_profiled":1310},"omim":[{"mim_id":"618229","title":"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7","url":"https://www.omim.org/entry/618229"},{"mim_id":"617228","title":"COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31; COXPD31","url":"https://www.omim.org/entry/617228"},{"mim_id":"603846","title":"NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 3; NDUFS3","url":"https://www.omim.org/entry/603846"},{"mim_id":"602241","title":"MITOCHONDRIAL INTERMEDIATE PEPTIDASE; MIPEP","url":"https://www.omim.org/entry/602241"},{"mim_id":"602184","title":"NADH-UBIQUINONE OXIDOREDUCTASE FLAVOPROTEIN 3; NDUFV3","url":"https://www.omim.org/entry/602184"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Mitochondria","reliability":"Approved"},{"location":"Nucleoplasm","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/NDUFV2"},"hgnc":{"alias_symbol":["CI-24k"],"prev_symbol":[]},"alphafold":{"accession":"P19404","domains":[{"cath_id":"1.10.10.1590","chopping":"33-125","consensus_level":"medium","plddt":92.968,"start":33,"end":125},{"cath_id":"3.40.30.10","chopping":"131-219","consensus_level":"high","plddt":95.767,"start":131,"end":219}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P19404","model_url":"https://alphafold.ebi.ac.uk/files/AF-P19404-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P19404-F1-predicted_aligned_error_v6.png","plddt_mean":86.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NDUFV2","jax_strain_url":"https://www.jax.org/strain/search?query=NDUFV2"},"sequence":{"accession":"P19404","fasta_url":"https://rest.uniprot.org/uniprotkb/P19404.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P19404/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P19404"}},"corpus_meta":[{"pmid":"12754703","id":"PMC_12754703","title":"Mutant NDUFV2 subunit of mitochondrial complex I causes early onset hypertrophic cardiomyopathy and encephalopathy.","date":"2003","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/12754703","citation_count":133,"is_preprint":false},{"pmid":"12815743","id":"PMC_12815743","title":"Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder.","date":"2003","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12815743","citation_count":70,"is_preprint":false},{"pmid":"17786189","id":"PMC_17786189","title":"Sp1 expression is disrupted in schizophrenia; a possible mechanism for the abnormal expression of mitochondrial complex I genes, NDUFV1 and NDUFV2.","date":"2007","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/17786189","citation_count":68,"is_preprint":false},{"pmid":"9570948","id":"PMC_9570948","title":"Genotype in the 24-kDa subunit gene (NDUFV2) of mitochondrial complex I and susceptibility to Parkinson disease.","date":"1998","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9570948","citation_count":55,"is_preprint":false},{"pmid":"15450783","id":"PMC_15450783","title":"Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder in Japanese and the National Institute of Mental Health pedigrees.","date":"2004","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/15450783","citation_count":53,"is_preprint":false},{"pmid":"19135101","id":"PMC_19135101","title":"Expression of mitochondrial complex I subunit gene NDUFV2 in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia.","date":"2008","source":"Neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/19135101","citation_count":52,"is_preprint":false},{"pmid":"34697471","id":"PMC_34697471","title":"Sex-specific genetic regulation of adipose mitochondria and metabolic syndrome by Ndufv2.","date":"2021","source":"Nature metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/34697471","citation_count":49,"is_preprint":false},{"pmid":"16508936","id":"PMC_16508936","title":"Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with schizophrenia in the Japanese population.","date":"2006","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16508936","citation_count":47,"is_preprint":false},{"pmid":"37451140","id":"PMC_37451140","title":"PHB2 ameliorates Doxorubicin-induced cardiomyopathy through interaction with NDUFV2 and restoration of mitochondrial complex I function.","date":"2023","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/37451140","citation_count":42,"is_preprint":false},{"pmid":"7607668","id":"PMC_7607668","title":"Molecular cloning and characterization of the active human mitochondrial NADH:ubiquinone oxidoreductase 24-kDa gene (NDUFV2) and its pseudogene.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7607668","citation_count":42,"is_preprint":false},{"pmid":"20971673","id":"PMC_20971673","title":"Genetic variation of the mitochondrial complex I subunit NDUFV2 and Parkinson's disease.","date":"2010","source":"Parkinsonism & related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/20971673","citation_count":37,"is_preprint":false},{"pmid":"21548921","id":"PMC_21548921","title":"Mitochondrial targeting of human NADH dehydrogenase (ubiquinone) flavoprotein 2 (NDUFV2) and its association with early-onset hypertrophic cardiomyopathy and encephalopathy.","date":"2011","source":"Journal of biomedical science","url":"https://pubmed.ncbi.nlm.nih.gov/21548921","citation_count":34,"is_preprint":false},{"pmid":"32353747","id":"PMC_32353747","title":"Low abundance of NDUFV2 and NDUFS4 subunits of the hydrophilic complex I domain and VDAC1 predicts mammalian longevity.","date":"2020","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/32353747","citation_count":29,"is_preprint":false},{"pmid":"18199248","id":"PMC_18199248","title":"Further support for association of the mitochondrial complex I subunit gene NDUFV2 with bipolar disorder.","date":"2008","source":"Bipolar disorders","url":"https://pubmed.ncbi.nlm.nih.gov/18199248","citation_count":28,"is_preprint":false},{"pmid":"7488192","id":"PMC_7488192","title":"Structural organization and chromosomal localization of the human nuclear gene (NDUFV2) for the 24-kDa iron-sulfur subunit of complex I in mitochondrial respiratory chain.","date":"1995","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/7488192","citation_count":27,"is_preprint":false},{"pmid":"26008862","id":"PMC_26008862","title":"Exome sequencing identifies complex I NDUFV2 mutations as a novel cause of Leigh syndrome.","date":"2015","source":"European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society","url":"https://pubmed.ncbi.nlm.nih.gov/26008862","citation_count":23,"is_preprint":false},{"pmid":"30531937","id":"PMC_30531937","title":"NDUFV2 pseudogene (NDUFV2P1) contributes to mitochondrial complex I deficits in schizophrenia.","date":"2018","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/30531937","citation_count":23,"is_preprint":false},{"pmid":"28219781","id":"PMC_28219781","title":"Adenosine A2 receptor activation ameliorates mitochondrial oxidative stress upon reperfusion through the posttranslational modification of NDUFV2 subunit of complex I in the heart.","date":"2017","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28219781","citation_count":21,"is_preprint":false},{"pmid":"33455045","id":"PMC_33455045","title":"Is the NDUFV2 subunit of the hydrophilic complex I domain a key determinant of animal longevity?","date":"2021","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/33455045","citation_count":14,"is_preprint":false},{"pmid":"26544616","id":"PMC_26544616","title":"A haplotype in the 5'-upstream region of the NDUFV2 gene is associated with major depressive disorder in Han Chinese.","date":"2015","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/26544616","citation_count":12,"is_preprint":false},{"pmid":"19194776","id":"PMC_19194776","title":"Association study on the mitochondrial gene NDUFV2 and bipolar disorder in the Chinese Han population.","date":"2009","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/19194776","citation_count":10,"is_preprint":false},{"pmid":"33811136","id":"PMC_33811136","title":"Whole genome and exome sequencing identify NDUFV2 mutations as a new cause of progressive cavitating leukoencephalopathy.","date":"2021","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33811136","citation_count":9,"is_preprint":false},{"pmid":"21190551","id":"PMC_21190551","title":"Common promoter variants of the NDUFV2 gene do not confer susceptibility to schizophrenia in Han Chinese.","date":"2010","source":"Behavioral and brain functions : BBF","url":"https://pubmed.ncbi.nlm.nih.gov/21190551","citation_count":7,"is_preprint":false},{"pmid":"34405929","id":"PMC_34405929","title":"Genome sequencing and RNA-seq analyses of mitochondrial complex I deficiency revealed Alu insertion-mediated deletion in NDUFV2.","date":"2021","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/34405929","citation_count":4,"is_preprint":false},{"pmid":"35471675","id":"PMC_35471675","title":"The NDUFV2 gene silencing inhibits the proliferation of two drug-resistant cancer cell lines.","date":"2022","source":"Journal, genetic engineering & biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/35471675","citation_count":3,"is_preprint":false},{"pmid":"40329774","id":"PMC_40329774","title":"Identification of NDUFV2, NDUFS7, OPA1, and NDUFA1 as biomarkers for Alzheimer's disease: Insights from oxidative stress and mitochondrial dysfunction in the hippocampus.","date":"2025","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/40329774","citation_count":3,"is_preprint":false},{"pmid":"36309697","id":"PMC_36309697","title":"Association between single-nucleotide polymorphism rs145497186 related to NDUFV2 and lumbar disc degeneration: a pilot case-control study.","date":"2022","source":"Journal of orthopaedic surgery and research","url":"https://pubmed.ncbi.nlm.nih.gov/36309697","citation_count":1,"is_preprint":false},{"pmid":"41419454","id":"PMC_41419454","title":"Hypoxic tumor exosomes suppress macrophage inflammation and ferroptosis via NDUFV2 to enhance bystander tumor radioresistance.","date":"2025","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/41419454","citation_count":0,"is_preprint":false},{"pmid":"39634239","id":"PMC_39634239","title":"A Novel NDUFV2 Variant in an Asymptomatic Adolescent Girl with Progressive Cavitating Leukoencephalopathy.","date":"2024","source":"Molecular syndromology","url":"https://pubmed.ncbi.nlm.nih.gov/39634239","citation_count":0,"is_preprint":false},{"pmid":"42040813","id":"PMC_42040813","title":"Expression Study of NDUFS1, NDUFV1, and NDUFV2 in Schizophrenia and Paranoid Personality Disorder : Role of Mitochondrial Complex I in SCZ and PPD.","date":"2022","source":"Galen medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/42040813","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.04.07.647592","title":"AMPK is dispensable for physiological podocyte and glomerular functions but prevents glomerular fibrosis in experimental diabetes","date":"2025-04-08","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.07.647592","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":16324,"output_tokens":2543,"usd":0.043558},"stage2":{"model":"claude-opus-4-6","input_tokens":5863,"output_tokens":2767,"usd":0.147735},"total_usd":0.191293,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"NDUFV2 encodes the 24-kDa iron-sulfur subunit of mitochondrial complex I (NADH:ubiquinone oxidoreductase), containing a [2Fe-2S] binuclear cluster (N1a), and is located on chromosome 18p11.2-p11.31; the gene spans ~20-31.5 kb with 8 exons and has a promoter with three putative GC boxes but no CAAT or TATA boxes.\",\n      \"method\": \"Molecular cloning, FISH chromosomal mapping, genomic sequencing\",\n      \"journal\": \"Genomics / Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — independent structural and genomic characterization by two labs\",\n      \"pmids\": [\"7607668\", \"7488192\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"A homozygous 4-bp deletion in intron 2 (IVS2+5_+8delGTAA) of NDUFV2 disrupts the consensus splice-donor site of exon 2, resulting in 70% decreased NDUFV2 protein and complex I deficiency, causing early-onset hypertrophic cardiomyopathy and encephalopathy.\",\n      \"method\": \"DHPLC and sequencing of patient DNA; protein quantification in patient tissue\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct genetic and biochemical demonstration in affected patients, replicated in subsequent studies\",\n      \"pmids\": [\"12754703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The transcription factor Sp1 directly activates NDUFV2 transcription by binding to three GC-boxes in the NDUFV2 promoter; treatment with the Sp1/DNA binding inhibitor mithramycin inhibits both Sp1 binding to the NDUFV2 promoter and NDUFV2 transcription in neuroblastoma cells.\",\n      \"method\": \"Promoter-reporter assay, chromatin immunoprecipitation (ChIP), mithramycin inhibition in neuroblastoma cells, RT-PCR\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct promoter binding and functional transcription assays with multiple orthogonal methods\",\n      \"pmids\": [\"17786189\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The mitochondrial targeting sequence (MTS) of NDUFV2 resides in its N-terminal 22 residues; the cleavage site is around amino acid 32. Correct mitochondrial import requires a net positive charge and amphiphilic structure in the presequence. The disease-causing deletion mutant (mimicking IVS2+5_+8delGTAA, lacking residues 19–40) exhibits significantly impaired mitochondrial targeting, establishing impaired mitochondrial import as the pathomechanism for hypertrophic cardiomyopathy/encephalopathy.\",\n      \"method\": \"GFP fusion constructs, c-myc epitope tagging, confocal microscopy, site-directed mutagenesis of the presequence\",\n      \"journal\": \"Journal of biomedical science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis combined with live-cell fluorescence imaging and functional localization assay\",\n      \"pmids\": [\"21548921\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Adenosine A2 receptor activation via NECA increases mitochondrial Src tyrosine kinase activity, leading to phosphorylation of Tyr118 of NDUFV2; this phosphorylation inhibits complex I activity and reduces mitochondrial superoxide generation at reperfusion. Cells expressing the Y118F mutant of NDUFV2 show increased complex I activity and NECA fails to suppress complex I at reperfusion in these cells.\",\n      \"method\": \"LC-MS phosphoproteomics, site-directed mutagenesis (Y118F), complex I activity assay in transfected cells, isolated rat heart ischemia/reperfusion model\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — LC-MS site identification combined with mutagenesis and functional enzyme assay\",\n      \"pmids\": [\"28219781\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The NDUFV2 pseudogene NDUFV2P1 is upregulated in schizophrenia-derived cell lines and postmortem brain; NDUFV2P1 expression inversely correlates with NDUFV2 protein level (both precursor and mature forms) and with complex I-driven cellular respiration, suggesting NDUFV2P1 negatively regulates NDUFV2 protein level without affecting mRNA, contributing to complex I dysfunction.\",\n      \"method\": \"qRT-PCR for pseudogene vs. gene transcripts, Western blot for protein isoforms, Seahorse respirometry, correlation analyses in patient-derived cell lines and postmortem brain\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — multiple methods in patient-derived material but mechanism of pseudogene-mediated regulation not fully reconstituted\",\n      \"pmids\": [\"30531937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Ndufv2 overexpression in adipose tissue regulates supercomplex assembly of mitochondrial complex I and elevates mitochondrial reactive oxygen species (ROS) production, which in turn generates a retrograde signal that increases mitochondrial biogenesis; Ndufv2 controls at least 89 mitochondrial genes in a sex- and tissue-specific manner in females.\",\n      \"method\": \"In vivo overexpression in mouse adipose tissue, supercomplex assembly assay (BN-PAGE), mitochondrial ROS measurement, gene expression profiling across diverse inbred mouse strains\",\n      \"journal\": \"Nature metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic overexpression with biochemical supercomplex and ROS assays plus transcriptomic evidence\",\n      \"pmids\": [\"34697471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PHB2 (Prohibitin 2) physically interacts with NDUFV2 and promotes its protein stabilization; PHB2 deficiency leads to downregulation of NDUFV2 protein and impairment of mitochondrial complex I activity and oxidative phosphorylation in doxorubicin-challenged hearts.\",\n      \"method\": \"Co-immunoprecipitation, pulldown assays, proteomic profiling, cardiac-specific PHB2 conditional knockout mice, in vivo and in vitro DOX cardiotoxicity models\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP and pulldown combined with genetic KO model and functional OXPHOS assays\",\n      \"pmids\": [\"37451140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"A -602G>A polymorphism in the promoter region of NDUFV2 alters promoter activity, as demonstrated by promoter assay; haplotypes containing this and a -3542G>A variant are associated with bipolar disorder in both Japanese and NIMH pedigrees.\",\n      \"method\": \"Promoter-reporter (luciferase) assay, case-control genotyping, transmission disequilibrium test\",\n      \"journal\": \"Biological psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional promoter assay combined with genetic association, single lab\",\n      \"pmids\": [\"15450783\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Three novel missense mutations in NDUFV2 identified in patients with progressive cavitating leukoencephalopathy affect the structural stability and function of the NDUFV2 protein; complementation with wild-type NDUFV2 cDNA rescued complex I deficiency in patient fibroblasts.\",\n      \"method\": \"Whole-genome/exome sequencing, cDNA complementation assay in fibroblasts, complex I activity assay\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — cDNA complementation directly links NDUFV2 loss-of-function to complex I deficiency\",\n      \"pmids\": [\"33811136\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NDUFV2 encodes the 24-kDa [2Fe-2S] iron-sulfur subunit (N1a cluster) of the N-module of mitochondrial respiratory complex I; its N-terminal 22-residue amphiphilic presequence directs mitochondrial import, where it is cleaved at ~residue 32; it is transcriptionally activated by Sp1 binding to GC-boxes in its promoter; its complex I activity is negatively regulated by Src-mediated phosphorylation at Tyr118; its protein stability is maintained through interaction with PHB2; it promotes mitochondrial supercomplex assembly and ROS-driven biogenesis in a sex-specific manner; and loss-of-function mutations cause complex I deficiency manifesting as hypertrophic cardiomyopathy, Leigh syndrome, or cavitating leukoencephalopathy.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"NDUFV2 encodes the 24-kDa [2Fe-2S] iron–sulfur subunit (cluster N1a) of the NADH-dehydrogenase N-module of mitochondrial respiratory complex I, serving as an essential determinant of complex I assembly, activity, and supercomplex organization. Its N-terminal amphiphilic presequence directs mitochondrial import with cleavage around residue 32, and disruption of this targeting — as occurs with the IVS2+5_+8delGTAA splice-site mutation — abolishes import and causes complex I deficiency [PMID:21548921, PMID:12754703]. Transcription is driven by Sp1 binding to GC-boxes in the TATA-less promoter [PMID:17786189]; at the post-translational level, Src-mediated phosphorylation of Tyr118 inhibits complex I activity during ischemia–reperfusion [PMID:28219781], while physical interaction with PHB2 stabilizes NDUFV2 protein and sustains oxidative phosphorylation [PMID:37451140]. Loss-of-function mutations cause complex I deficiency presenting as hypertrophic cardiomyopathy, Leigh-like encephalopathy, or progressive cavitating leukoencephalopathy [PMID:12754703, PMID:33811136].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Establishing the molecular identity of NDUFV2 as the 24-kDa [2Fe-2S] complex I subunit mapped to 18p11 resolved which nuclear gene encodes this iron–sulfur center and revealed a TATA-less, GC-box-containing promoter architecture.\",\n      \"evidence\": \"Molecular cloning, FISH mapping, and genomic sequencing by two independent groups\",\n      \"pmids\": [\"7607668\", \"7488192\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No functional demonstration that the GC-boxes drive transcription\",\n        \"No disease mutations yet identified\",\n        \"Mitochondrial import mechanism not characterized\"\n      ]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identification of the IVS2+5_+8delGTAA splice-site mutation causing 70% loss of NDUFV2 protein and complex I deficiency demonstrated that NDUFV2 loss-of-function is sufficient to cause early-onset hypertrophic cardiomyopathy and encephalopathy.\",\n      \"evidence\": \"DHPLC/sequencing of patient DNA with protein quantification in affected tissue\",\n      \"pmids\": [\"12754703\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Pathomechanism (impaired import vs. protein instability) not yet distinguished\",\n        \"No complementation rescue performed\",\n        \"Only a single family studied\"\n      ]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"A promoter polymorphism (−602G>A) was shown to alter NDUFV2 transcriptional activity and associate with bipolar disorder, providing the first evidence that quantitative variation in NDUFV2 expression has neuropsychiatric consequences.\",\n      \"evidence\": \"Luciferase promoter-reporter assay combined with case-control and TDT genetic association\",\n      \"pmids\": [\"15450783\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Association not replicated across multiple independent cohorts at the time\",\n        \"Downstream effect on complex I activity in brain not measured\",\n        \"Causal transcription-factor binding change at −602 not identified\"\n      ]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstrating that Sp1 directly binds the three GC-boxes and activates NDUFV2 transcription resolved the transcriptional regulation of this TATA-less gene.\",\n      \"evidence\": \"ChIP, promoter-reporter assays, and mithramycin inhibition in neuroblastoma cells\",\n      \"pmids\": [\"17786189\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Additional transcription factors or chromatin regulators not explored\",\n        \"Tissue-specific regulation not addressed\",\n        \"Link between Sp1 activity changes and disease states not tested\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Mapping the mitochondrial targeting sequence to residues 1–22 and the cleavage site to ~residue 32 established that the IVS2-linked deletion (Δ19–40) causes disease specifically by abolishing mitochondrial import of NDUFV2.\",\n      \"evidence\": \"GFP/c-myc fusion constructs with site-directed mutagenesis and confocal microscopy\",\n      \"pmids\": [\"21548921\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Import pathway components (TIM/TOM dependence) not identified\",\n        \"Whether partially imported mutant protein is degraded was not shown\",\n        \"Complementation in patient cells not performed\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identification of Src-mediated Tyr118 phosphorylation as a negative regulatory switch for complex I activity revealed a rapid post-translational mechanism linking receptor signaling to mitochondrial electron transport during ischemia–reperfusion.\",\n      \"evidence\": \"LC-MS phosphoproteomics, Y118F mutagenesis, complex I activity assay, and rat heart ischemia–reperfusion model\",\n      \"pmids\": [\"28219781\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis for how pY118 inhibits electron transfer through the N1a cluster not resolved\",\n        \"Whether other kinases phosphorylate NDUFV2 at additional sites is unknown\",\n        \"In vivo significance beyond cardiac ischemia–reperfusion not tested\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Discovery that the pseudogene NDUFV2P1 inversely regulates NDUFV2 protein level without affecting mRNA suggested a post-transcriptional layer of complex I regulation relevant to schizophrenia-associated bioenergetic deficits.\",\n      \"evidence\": \"qRT-PCR, Western blot, and Seahorse respirometry in patient-derived cell lines and postmortem brain\",\n      \"pmids\": [\"30531937\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism of pseudogene-mediated post-transcriptional regulation not reconstituted\",\n        \"Causal role of NDUFV2P1 not demonstrated by knockdown/overexpression rescue\",\n        \"Findings limited to correlative patient-derived material\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"In vivo overexpression of Ndufv2 in adipose tissue showed it promotes mitochondrial supercomplex assembly and ROS-driven retrograde signaling that increases mitochondrial biogenesis in a sex-specific manner, extending NDUFV2's role beyond electron transfer to organelle homeostasis.\",\n      \"evidence\": \"Mouse adipose-specific overexpression, BN-PAGE supercomplex assay, mitochondrial ROS measurement, transcriptomics across inbred strains\",\n      \"pmids\": [\"34697471\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the supercomplex-assembly function is direct or secondary to increased N-module incorporation is unclear\",\n        \"Mechanism of sex specificity not identified\",\n        \"Relevance to non-adipose tissues not established\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"cDNA complementation rescue of complex I deficiency in fibroblasts from patients carrying novel NDUFV2 missense mutations confirmed causality for progressive cavitating leukoencephalopathy, broadening the phenotypic spectrum of NDUFV2-linked disease.\",\n      \"evidence\": \"Whole-exome sequencing plus cDNA complementation and complex I activity assay in patient fibroblasts\",\n      \"pmids\": [\"33811136\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural effects of individual missense mutations on the [2Fe-2S] cluster not resolved\",\n        \"Genotype–phenotype correlation across cardiomyopathy vs. leukoencephalopathy not mechanistically explained\",\n        \"No animal model recapitulating these specific mutations\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Demonstrating that PHB2 physically interacts with and stabilizes NDUFV2 protein identified a chaperone-like quality-control mechanism for maintaining complex I integrity, particularly under cardiotoxic stress.\",\n      \"evidence\": \"Reciprocal Co-IP, pulldown, proteomics, cardiac-specific PHB2 knockout mice, doxorubicin cardiotoxicity model\",\n      \"pmids\": [\"37451140\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether PHB2 stabilizes NDUFV2 during or after mitochondrial import is unknown\",\n        \"Binding interface between PHB2 and NDUFV2 not mapped\",\n        \"Whether PHB2 similarly stabilizes other N-module subunits not tested\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A high-resolution structural understanding of how post-translational modifications (Tyr118 phosphorylation) and protein–protein interactions (PHB2 binding) regulate NDUFV2 within the assembled complex I supercomplex, and how genotype dictates tissue-specific disease manifestation, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No atomic-resolution structure of human NDUFV2 in context of modified or PHB2-bound complex I\",\n        \"Mechanism underlying tissue-specific and sex-specific phenotypic outcomes not elucidated\",\n        \"Contribution of pseudogene NDUFV2P1 to complex I regulation awaits direct genetic perturbation\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [0, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 3, 6, 7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 4, 6, 7]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [1, 9]}\n    ],\n    \"complexes\": [\n      \"Mitochondrial complex I (NADH:ubiquinone oxidoreductase)\"\n    ],\n    \"partners\": [\n      \"PHB2\",\n      \"SRC\",\n      \"SP1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}